| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 2,215 | 2,415 | 2,508 | 2,522 | 2,582 | 2,850 | 2,922 | 3,125 | 2,179 | 2,808 | 2,781 | 2,931 | 4,079 | 3,725 | 3,662 | 3,580 | 3,812 | 4,274 | 4,299 | 4,322 | 4,452 | 4,873 | 4,880 | 4,981 | 5,134 | 5,633 | 5,596 |
| Expenses | 1,981 | 2,141 | 2,222 | 2,220 | 2,218 | 2,427 | 2,482 | 2,542 | 2,159 | 2,470 | 2,370 | 2,456 | 3,245 | 3,102 | 3,052 | 3,083 | 3,317 | 3,699 | 3,780 | 3,814 | 3,909 | 4,219 | 4,237 | 4,303 | 4,411 | 4,774 | 4,765 |
| EBITDA | 234 | 274 | 286 | 302 | 364 | 423 | 440 | 583 | 21 | 337 | 411 | 475 | 835 | 623 | 610 | 497 | 495 | 575 | 519 | 508 | 543 | 654 | 643 | 677 | 724 | 859 | 831 |
| Operating Profit % | 10 % | 11 % | 11 % | 11 % | 14 % | 15 % | 15 % | 13 % | 1 % | 11 % | 14 % | 14 % | 14 % | 17 % | 16 % | 13 % | 13 % | 13 % | 11 % | 11 % | 12 % | 13 % | 13 % | 13 % | 13 % | 15 % | 14 % |
| Depreciation | 95 | 97 | 98 | 105 | 144 | 155 | 157 | 164 | 160 | 149 | 125 | 139 | 141 | 145 | 149 | 166 | 148 | 155 | 153 | 159 | 167 | 163 | 167 | 190 | 177 | 185 | 185 |
| Interest | 76 | 81 | 84 | 85 | 126 | 134 | 137 | 135 | 127 | 122 | 101 | 99 | 95 | 95 | 94 | 95 | 93 | 93 | 100 | 95 | 106 | 111 | 113 | 119 | 116 | 118 | 110 |
| Profit Before Tax | 63 | 96 | 103 | 112 | 94 | 134 | 145 | 284 | -267 | 66 | 185 | 238 | 599 | 383 | 368 | 236 | 254 | 327 | 266 | 254 | 270 | 379 | 363 | 368 | 430 | 557 | 536 |
| Tax | 39 | 42 | 53 | 39 | 45 | 51 | 55 | 74 | -41 | 7 | 51 | 68 | 99 | 116 | 124 | 139 | -70 | 114 | 104 | 108 | 97 | 130 | 109 | 110 | 115 | 162 | 157 |
| Net Profit | 23 | 54 | 50 | 73 | 49 | 83 | 90 | 210 | -226 | 59 | 134 | 170 | 501 | 267 | 243 | 97 | 324 | 213 | 162 | 146 | 173 | 249 | 254 | 258 | 316 | 396 | 379 |
| EPS in ₹ | 2.44 | 4.56 | 4.10 | 6.10 | 4.11 | 6.20 | 6.62 | 15.77 | -14.96 | 4.33 | 9.38 | 11.77 | 34.03 | 17.24 | 15.88 | 6.27 | 22.05 | 14.19 | 10.67 | 10.05 | 11.59 | 16.20 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 |
Apollo Hospitals
6,780.95
-53.15
(-0.78%)
Market Cap
97,499.66 Cr
EPS
62.50
PE Ratio
74.99
Dividend Yield
0.23 %
Industry
Healthcare Services52 Week High
7,545.35
52 Week Low
5,693.20
PB Ratio
13.11
Debt to Equity
0.74
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from24 analysts
Company News
View All News
Apollo Hospitals: Expansion Plans Target North India Through Acquisitions3 days ago
Apollo Hospitals Enterprise Ltd. is seeking acquisitions to expand its presence in northern India and other key urban centers. The company plans to add 3,500 beds over 3-4 years, focusing on cities like Kolkata, Hyderabad, and Mumbai. Apollo is also investing in a $29 million cancer center and sees growth in oncology, cardiac, neurology, and preventive healthcare.
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,089.30 | #1 1,05,895.43 | 103.08 | 5,584.10 | 18.77 | #1 1,058 | -17.46 | 51.00 | |
6,780.95 | #2 97,499.66 | #8 74.99 | #1 19,165.50 | #5 14.74 | #2 917 | #2 49.14 | 62.56 | |
649.55 | 49,038.31 | 62.57 | 6,931.20 | 8.99 | 645 | #1 89.49 | 51.60 | |
1,699.95 | 34,740.31 | 44.06 | 5,093.40 | 10.96 | 790 | 2.66 | 63.10 | |
1,269.95 | 34,109.25 | 65.05 | 2,759.20 | #1 25.09 | 326 | 15.71 | 59.10 | |
500.30 | 24,990.64 | 93.82 | 3,723.70 | 22.85 | 205 | -69.22 | 72.68 | |
616.75 | 24,678.57 | 68.22 | 2,511.20 | 12.94 | 336 | 20.76 | 56.67 | |
1,530.85 | 15,546.04 | 63.54 | 1,334.00 | 10.76 | 218 | 10.06 | 74.19 | |
5,500.00 | 12,539.44 | #1 28.46 | 599.90 | 11.69 | 58 | 8.85 | 51.81 | |
1,450.55 | 9,510.68 | 48.56 | 1,095.50 | 21.32 | 177 | 20.14 | 39.35 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
14.74 %
Net Income Growth
3.32 %
Cash Flow Change
39.46 %
ROE
-7.80 %
ROCE
9.18 %
EBITDA Margin (Avg.)
1.72 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 |
| Fixed Assets | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,778 | 8,296 | 8,520 | 9,664 |
| Current Assets | 1,939 | 1,975 | 2,129 | 2,220 | 2,282 | 2,647 | 3,641 | 4,061 | 4,337 | 5,280 |
| Capital Work in Progress | 533 | 562 | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 |
| Investments | 146 | 352 | 406 | 352 | 462 | 434 | 1,343 | 816 | 574 | 986 |
| Other Assets | 2,557 | 2,448 | 2,775 | 2,776 | 2,918 | 3,237 | 3,062 | 4,112 | 4,725 | 5,230 |
| Total Liabilities | 6,479 | 7,360 | 8,119 | 8,613 | 9,183 | 11,338 | 11,417 | 13,269 | 14,428 | 16,753 |
| Current Liabilities | 1,076 | 1,250 | 963 | 1,567 | 1,956 | 2,337 | 2,038 | 2,434 | 3,325 | 4,665 |
| Non Current Liabilities | 2,159 | 2,701 | 3,718 | 3,662 | 3,759 | 5,531 | 4,577 | 4,932 | 4,572 | 4,768 |
| Total Equity | 3,244 | 3,409 | 3,438 | 3,384 | 3,469 | 3,470 | 4,802 | 5,903 | 6,531 | 7,321 |
| Reserve & Surplus | 3,101 | 3,262 | 3,240 | 3,182 | 3,264 | 3,270 | 4,531 | 5,551 | 6,126 | 6,864 |
| Share Capital | 70 | 70 | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 103 | 39 | -52 | 24 | -20 | 95 | 45 | 158 | -113 | 72 |
| Investing Activities | -759 | -888 | -1,152 | -405 | -711 | -289 | -880 | -747 | -857 | -1,537 |
| Operating Activities | 470 | 597 | 623 | 537 | 905 | 1,293 | 1,265 | 1,696 | 1,377 | 1,920 |
| Financing Activities | 392 | 330 | 477 | -109 | -215 | -910 | -340 | -792 | -633 | -311 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 29.82 % | 29.82 % | 29.82 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.33 % | 29.34 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 45.63 % | 43.92 % | 45.37 % | 45.27 % | 42.74 % |
| DIIs | 9.16 % | 10.84 % | 12.24 % | 12.13 % | 12.45 % | 14.89 % | 14.59 % | 16.56 % | 17.76 % | 16.31 % | 18.60 % | 17.97 % | 19.55 % | 21.14 % | 19.95 % | 19.98 % | 22.29 % |
| Government | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % | 0.23 % |
| Public / Retail | 4.07 % | 3.99 % | 4.24 % | 4.03 % | 4.27 % | 4.48 % | 4.23 % | 4.13 % | 4.04 % | 3.90 % | 4.04 % | 3.70 % | 3.74 % | 3.81 % | 3.62 % | 3.65 % | 3.81 % |
| Others | 56.73 % | 55.13 % | 53.47 % | 54.29 % | 53.73 % | 51.07 % | 51.63 % | 49.75 % | 48.64 % | 50.23 % | 47.80 % | 48.76 % | 1.52 % | 1.57 % | 1.50 % | 1.54 % | 1.60 % |
| No of Share Holders | 67,091 | 75,153 | 98,452 | 99,135 | 1,26,226 | 1,46,320 | 1,35,923 | 1,31,636 | 1,31,937 | 1,20,030 | 1,31,565 | 1,19,578 | 1,30,664 | 1,27,754 | 1,19,245 | 1,27,802 | 1,34,058 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 6 | 5 | 6 | 6 | 3 | 11.75 | 15 | 16 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.56 | 0.41 | 0.53 | 0.21 | 0.07 | 0.27 | 0.24 | 0.24 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
4 days ago
4 days agoClosure of Trading WindowMar 24, 2025
Mar 24, 2025Disclosure Pursuant To Regulation 30 Of SEBI LODRMar 21, 2025
Mar 21, 2025Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)Mar 14, 2025
Mar 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Mar 04, 2025
Mar 04, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - RevisedMar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 04, 2025
Mar 04, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 04, 2025
Mar 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Feb 10, 2025Integrated Filing (Financial)Feb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesFeb 10, 2025
Feb 10, 2025Board Meeting Outcome for Outcome Of The Board MeetingFeb 10, 2025
Feb 10, 2025Unaudited Financial Results For Three And Nine Months Ended 31St December 2024Feb 10, 2025
Feb 10, 2025Update on board meetingFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2025
Jan 30, 2025Board Meeting Intimation for Notice Of The Board MeetingJan 18, 2025
Jan 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025
Jan 11, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Nov 28, 2024
Nov 28, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 15, 2024
Nov 15, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2024
Nov 12, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2024
Nov 07, 2024Limited Review Report On Unaudited Financial Results For The Three And Six Months Ended September 30, 2024 With UDINNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2024
Nov 06, 2024Board Meeting Outcome for Financial Results For The Three And Six Months Ended 30Th September 2024Nov 06, 2024
Nov 06, 2024Financial Results For The Three And Six Months Ended 30Th Sept 2024Nov 06, 2024
Nov 06, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 06, 2024
Nov 06, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 01, 2024
Nov 01, 2024Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Capacity AdditionNov 01, 2024
Nov 01, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 30, 2024
Oct 30, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 25, 2024
Oct 25, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 18, 2024
Oct 18, 2024Board Meeting Intimation for Notice Of The Board MeetingOct 15, 2024
Oct 15, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 15, 2024
Oct 15, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Oct 09, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 08, 2024
Oct 08, 2024Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended ('Listing Regulations') - Dilution Of Shareholding Of Apollo Hospitals Enterprise Limited ('Company') In Apollo Healthco Ltd, A Material Subsidiary Of The CompanySep 27, 2024
Sep 27, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 23, 2024
Sep 23, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 17, 2024
Sep 17, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 16, 2024
Sep 16, 2024Announcement under Regulation 30 (LODR)-AcquisitionSep 11, 2024
Sep 11, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 11, 2024
Sep 11, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 05, 2024
Sep 05, 2024Announcement under Regulation 30 (LODR)-AcquisitionSep 04, 2024
Sep 04, 2024Announcement under Regulation 30 (LODR)-Updates on AcquisitionSep 04, 2024
Sep 04, 2024Technical Indicators
RSI(14)
Neutral 62.56
ATR(14)
Less Volatile 143.45
STOCH(9,6)
Overbought 81.93
STOCH RSI(14)
Overbought 85.55
MACD(12,26)
Bullish 33.53
ADX(14)
Weak Trend 17.05
UO(9)
Bearish 66.46
ROC(12)
Uptrend And Accelerating 2.50
WillR(14)
Neutral -20.42
About Apollo Hospitals
Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in 43 owned hospitals, 305 beds in 11 cradles, 257 beds in 11 day care/short surgical stay centers, and 851 beds in 5 hospitals operated through management contracts. The company has expanded through acquisitions, joint ventures, and new facility launches. AHEL has also diversified into health insurance, retail pharmacy, and digital healthcare platforms. The company has undergone various corporate restructurings to optimize its business operations across different healthcare segments.
Chairperson NameShobana Kamineni
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
